News

  • On October 19th 2021 a small VIMM delegation was received by the President of the Italian Republic Sergio Mattarella at Quirinale, celebrating 25 years of our Foundation. An important day to remember for the Foundation and its operational arm, the Veneto Institute of Molecular Medicine (VIMM), which today counts on a team of 180 researchers […]

    READ MORE
  • An article was published today in the prestigious scientific journal “Science” that testifies to a very important discovery on the mechanisms in the human intestine that could in the future change the therapeutic approach in cases of prostate tumors that have become resistant to castration. The study was led by prof. Andrea Alimonti, Principal Investigator […]

    READ MORE
  • Fenofibrate, a drug routinely used for the treatment of high levels of triglycerides, is able to stimulate the level of circulating stem cells in patients with diabetic retinopathy: this is what emerges from a study conducted by researchers from the Veneto Institute of Molecular Medicine (VIMM ) and of the Department of Medicine of the […]

    READ MORE
  • The growth of a tumor within the human body causes functional, structural and metabolic changes in the tissues that lead to the progressive worsening of the patient’s condition. In most cases, the neoplasm alters the normal muscle contractile and metabolic capacity, often inducing in patients a state of fatigue, tiredness and “shortness of breath” which […]

    READ MORE
  • When we are at rest, that is, in sleep or in the absence of particular tasks, our brain produces spontaneous activity that resembles that recorded during active behavior, but whose role is still debated. A possible description of this activity comes from a theoretical study published in the journal “Trends in Cognitive Sciences” by Giovanni […]

    READ MORE
  • Learn more about the RAI1 gene, a gene that plays a fundamental role from the earliest stages of embryo development. Understanding how its malfunction is at the origin of very severe rare diseases (such as Smith-Magenis and Potocki-Lupski) but, also, if it is responsible for more common pathologies of childhood neurodevelopment, characterized by learning and […]

    READ MORE
  • The role of a specific protein, PKA (protein kinase A), is essential in some types of cells for autophagy. Autophagy is the physiological process through which our cells get rid of damaged components. This discovery could open new therapeutic strategies for degenerative diseases and tumors. This is the result achieved by the recently published study, conducted by […]

    READ MORE
  • Three high profiles to choose an equally high profile: the new VIMM Scientific Director. The Foundation for Advanced Biomedical Research has chosen Professor Alberto Mantovani, Director of Humanitas Research Institute of Milan, Professor Maria Grazia Roncarolo, Director of the Institute for Stem Cell Biology and Regenerative Medicine of Stanford CA, and Prof. Giuseppe Remuzzi, Director […]

    READ MORE
  • VIMM postdoctoral researcher affiliated with Luca Scorrano’s group, Akiko Omori, won a research grant from the Umberto Veronesi Foundation, with an experimental project against prostate tumors. More specifically, Dr. Omori’s goal is to identify a new therapeutic approach for patients affected by prostate tumors that do not resolve with the conventional administration of antiandrogenic drugs. […]

    READ MORE
  • Fighting a genetic eye disease that leads to progressive blindness: Schnyder’s corneal dystrophy (SCD). This is the aim of Massimo Santoro‘s research project, who is professor at University of Padua and Principal Investigator at Advanced Biomedical Research Foundation – VIMM. Telethon Foundation has guaranteed its team a loan of 240 thousand euros for the three-year […]

    READ MORE
V.I.M.M. © 2018 - credits